Potenza and microneedle radiofrequency: what it treats well

What microneedle radiofrequency is

Ordinary radiofrequency devices put energy in through the skin surface, which means the epidermis takes heat on the way to wherever the treatment is aimed. Microneedle radiofrequency avoids that: fine needles carry the current through the epidermis and release it at a depth the operator sets.

So there are two mechanisms working at once — the mechanical injury of the needle and the thermal injury of the energy at its tip — and one important property: the surface is comparatively spared.

Potenza is one such device. Sylfirm is another. Korean clinics sell them by name rather than by category, which is why the three arrangements are worth knowing.

What the evidence supports

A 2026 systematic review in Aesthetic Plastic Surgery covered 41 studies — 15 randomised controlled trials, 19 prospective non-randomised studies, 5 retrospective cohorts, 2 case series — totalling over a thousand patients across several countries. What it found, by indication:

Indication	Reported improvement
Atrophic acne scars	26–100% reduction in scar scores; comparable to fractional lasers
Skin laxity and wrinkles	18–75%
Photoaging	25–100% wrinkle improvement
Rosacea	81% of patients improved
Stretch marks	Comparable to CO2 laser
Underarm sweating	Botulinum toxin outperformed it

Those ranges are wide, and the width is the honest part: different scar types, devices, needle depths, and energy settings produce genuinely different results. The reviewers' conclusion asks for "rigorous reporting of device settings" precisely because that variation is not yet controlled for.

The property that makes it a good fit here

For an international audience — and this site's readers are largely in East and Southeast Asia and Australia — the finding that matters most is about skin type.

The review reports consistent safety across Fitzpatrick skin types, with post-inflammatory hyperpigmentation in 2.9–5% of cases, mild and transient adverse events, and no serious complications across the included trials.

That is a meaningful contrast with ablative and high-fluence laser treatment, where the central risk in pigmented skin is provoking more pigment. Because the energy is delivered past the epidermis rather than through it, microneedle radiofrequency sidesteps much of that. It is a large part of why it is chosen for Asian skin, and it is a better reason than the brand marketing usually given.

Acne scars specifically

This is where the evidence is strongest and where the treatment is most worth considering. Scar scores fell by 26–100% across the studies, and the reviewers describe efficacy as comparable to fractional lasers.

What that does not mean is a single-session fix. Atrophic scars respond over a course and continue remodelling for months afterwards, and the type of scar matters — different scar shapes respond at different rates. A clinic that assesses your scar types before proposing a number of sessions is doing the right thing; one that quotes a package before looking is not.

Brand against brand

Potenza and Sylfirm are both sold with claims of distinct advantages. The systematic review's closing request — standardised outcomes, longer follow-up, and rigorous reporting of device settings to "facilitate head-to-head device comparisons" — tells you those comparisons have not been done.

So a claim that one device outperforms another is, at present, unevidenced. What is evidenced is the category.

Questions to ask a Korean clinic

• Which device, and what is its Korean product name?
• What needle depth and energy level, and why those for my skin?
• Are the needles insulated, and what difference does that make here?
• What scar types do I have, and how does that change the plan?
• How many sessions, at what interval, and what is the total?

The bottom line

Microneedle radiofrequency delivers energy past the epidermis to a depth the operator chooses. A 2026 review of 41 studies found credible efficacy across several indications — strongest for atrophic acne scars, where it is comparable to fractional lasers — with mild, transient side effects and consistent safety across skin types, post-inflammatory hyperpigmentation at 2.9–5%. That skin type safety is the real argument for it. Claims that one brand beats another are not yet supported by evidence.